Fanconi Anemia, Complementation Group C; Fancc
Description
Fanconi anemia is a clinically and genetically heterogeneous disorder that causes genomic instability. Characteristic clinical features include developmental abnormalities in major organ systems, early-onset bone marrow failure, and a high predisposition to cancer. The cellular hallmark of FA is hypersensitivity to DNA crosslinking agents and high frequency of chromosomal aberrations pointing to a defect in DNA repair (summary by Deakyne and Mazin, 2011).For additional general information and a discussion of genetic heterogeneity of Fanconi anemia, see {227650}.
Clinical Features
Top most frequent phenotypes and symptoms related to Fanconi Anemia, Complementation Group C; Fancc
- Intellectual disability
- Short stature
- Hearing impairment
- Microcephaly
- Neoplasm
- Strabismus
- Cryptorchidism
- Anemia
- Microphthalmia
- Abnormality of cardiovascular system morphology
And another 24 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Fanconi Anemia, Complementation Group C; Fancc Is also known as facc, fac, fa3, fanconi pancytopenia, type 3.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Fanconi Anemia, Complementation Group C; Fancc Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Ashkenazic Genetic Disease Screen (with Cystic Fibrosis).
By Baylor Miraca Genetics Laboratories (United States).
SMPD1, FANCC, GBA, ELP1, ASPA
Specificity
20 %
Genes
100 % |
Ashkenazic Genetic Disease Screen (without Cystic Fibrosis).
By Baylor Miraca Genetics Laboratories (United States).
SMPD1, FANCC, GBA, ELP1, ASPA
Specificity
20 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
100 % |
GeneAware Ashkenazi Jewish Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
BLM, SLC35A3, SMN1, SMPD1, CLRN1, MCOLN1, PCDH15, RTEL1, CFTR, SUMF1, DHDDS, ADAMTS2, COL4A3, CPT2, TMEM216, DHCR7, DLD, DMD, FAH, FANCC , (...)
View the complete list with 19 more genes
Specificity
3 %
Genes
100 % |
GeneAware ACMG/ACOG Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
BLM, SMN1, SMPD1, MCOLN1, CFTR, FANCC, GBA, HBA1, HBA2, HBB, HEXA, ELP1, ASPA
Specificity
8 %
Genes
100 % |
GeneAware Ashkenazi Jewish Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
BLM, SLC35A3, SMN1, SMPD1, CLRN1, MCOLN1, PCDH15, RTEL1, CFTR, SUMF1, DHDDS, ADAMTS2, COL4A3, CPT2, TMEM216, DHCR7, DLD, FAH, FANCC, FKTN , (...)
View the complete list with 17 more genes
Specificity
3 %
Genes
100 % |
GeneAware ACMG/ACOG Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
BLM, SMN1, SMPD1, MCOLN1, CFTR, DMD, FANCC, FMR1, GBA, HBA1, HBA2, HBB, HEXA, ELP1, ASPA
Specificity
7 %
Genes
100 % |
You can get up to 124 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPINOCEREBELLAR ATAXIA 28; SCA28 MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22